We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Oxeco | LSE:OXE | London | Ordinary Share | GB00B1J5QT30 | ORD 0.1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 2.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
Hot Features
Premium
TIDMOXE
RNS Number : 3535O
Oxeco PLC
28 June 2010
Oxeco plc (the "Company")
Result of General Meeting
Further to the announcement on 3 June 2010 in relation to the proposed
acquisition of Tissue Regenix Limited, the Company is pleased to announce that
all resolutions proposed were duly passed at the General Meeting held earlier
today.
Dealings in the enlarged group will commence on 29 June 2010 under the name of
Tissue Regenix Group Plc with the TIDM (ticker symbol) "TRX". A copy of the
admission document and relevant information provided under AIM Rule 26 will be
available from the Company's website at www.tissueregenix.com.
Contact
+----------------------------------------+----------------------------------------+
| Michael Bretherton | +44 (0) 20 7099 7266 |
| Oxeco plc | |
| | |
+----------------------------------------+----------------------------------------+
| Graeme Thom/ Sarang Shah | +44 (0) 20 7060 2220 |
| ZAI Corporate Finance Ltd | |
| | |
+----------------------------------------+----------------------------------------+
This information is provided by RNS
The company news service from the London Stock Exchange
END
ROMLLFLVRAITFII
1 Year Oxeco Chart |
1 Month Oxeco Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
